Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$118.38 - $210.04 $447,476 - $793,951
3,780 New
3,780 $678,000
Q2 2022

Aug 15, 2022

SELL
$117.13 - $176.59 $163,630 - $246,696
-1,397 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$126.46 - $235.05 $176,664 - $328,364
1,397 New
1,397 $241,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Eschler Asset Management LLP Portfolio

Follow Eschler Asset Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eschler Asset Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Eschler Asset Management LLP with notifications on news.